Invention Grant
- Patent Title: Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
-
Application No.: US15317553Application Date: 2015-06-05
-
Publication No.: US09796713B2Publication Date: 2017-10-24
- Inventor: Ivar M. McDonald , Richard E. Olson , Robert A. Mate
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- International Application: PCT/US2015/034542 WO 20150605
- International Announcement: WO2015/191401 WO 20151217
- Main IPC: C07D471/18
- IPC: C07D471/18 ; C07D519/00
Abstract:
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.
Public/Granted literature
- US20170129892A1 TRICYCLIC COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS Public/Granted day:2017-05-11
Information query
